Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
After telehealth startups just lately misplaced the flexibility to promote actual copies of patented GLP-1 weight-loss medication, some corporations have begun turning to a distinct, much less efficient treatment that ...
